Plain-English translation of NCT07460154 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial offers people with COPD who have frequent flare-ups (3 or more per year) a structured, comprehensive health assessment. The assessment aims to confirm your COPD diagnosis, identify any other health conditions you may have that weren't previously diagnosed, and find specific health factors that, when treated, could reduce how often you have flare-ups.
Many people with COPD who have frequent flare-ups are not receiving the right care or treatment. Sometimes people are misdiagnosed with COPD when they actually have a different condition, or they have other serious health problems (like heart disease) that aren't being treated and make their breathing symptoms worse. Additionally, frequent use of steroid tablets to treat flare-ups can cause serious side effects like bone loss and diabetes. This trial wants to make sure people get the right diagnosis and targeted care to prevent unnecessary flare-ups and reduce harmful steroid use.
You likely qualify if…
You likely don't qualify if…
You would attend a structured health assessment appointment where healthcare professionals will review your medical history, confirm your COPD diagnosis, perform physical examinations and tests, assess you for other health conditions you may have, and identify specific health factors (related to your lungs, overall health, and lifestyle) that could be improved. The assessment will also include educational support tailored to your needs. Based on what is found, you'll receive a personalized plan to optimize your treatment and reduce your risk of future flare-ups.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
United Kingdom